Sanderling Ventures — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

TheravidaJan 2023

HealthtechChapel Hill, US

Mehdi Paborji(Executive Officer, Director)Roger L. Flugel(Executive Officer, Director)Roger S. Flugel(Executive Officer, Director)

BoardNasser J. Kazeminy(Director)Fred A. Middleton(Director)Benjamin F. McGraw III(Executive Officer, Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.